News
FDA urges drug makers to establish risk management plans to reduce drug shortages
31 May 2022
PartnerWashington, D.C.
Email [email protected]hoganlovells.com
Phone +1 202 637 5600
Fax +1 202 637 5910
Practice groupGlobal Regulatory
David Horowitz brings 25 years of combined experience at the U.S. Department of Health and Human Services (HHS) and the FDA to help clients anticipate and navigate regulatory challenges, and participating in the policy-making process.
As Deputy General Counsel at HHS (2010-2017), David oversaw and coordinated legal services in support of FDA, the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and international and emergency preparedness programs. His work focused on FDA regulatory policy and litigation. During his tenure at FDA – which included five years as head of the Office of Compliance for drugs, and three years as Assistant Commissioner for Compliance Policy – David played a leadership role in major initiatives, including the modernization of FDA's approach to pharmaceutical manufacturing quality and the agency's efforts to develop and implement a more scientific, risk-based approach to inspection and enforcement.
Over the course of his career at HHS and FDA, David developed substantial knowledge pertaining to FDA law and policy, with particular emphasis on pharmaceuticals, compliance, and the application of administrative law. He also developed a deep understanding of the institutions, organizational structures, procedures, and cultures through which regulatory policy and compliance decisions are considered, developed, and implemented across all branches of government, including Congress and the courts, as well as various components of FDA, HHS, Office of Management and Budget, Department of Justice, and the White House.
Healthcare: Life Sciences
Legal 500 US
Meritorious Service
Presidential Rank Award
Distinguished Service and Leadership Award
Food and Drug Law Institute
NIH Director's Award
NIH
FDA Award of Merit
FDA
FDA Commissioner's Special Citation
FDA
HHS Certificate of Appreciation
HHS
Education
J.D., University of Virginia School of Law, 1991
B.A., Brown University, magna cum laude, 1986
Bar admissions and qualifications
District of Columbia
Pennsylvania
Court admissions
U.S. Supreme Court
U.S. Court of Appeals, Fifth Circuit
Lead agency counsel for all HHS legal issues relating to Ebola outbreak, including FDA Emergency Use Authorizations and vaccine development and liability matters*
FDA leader in developing internationally harmonized pharmaceuticals guideline on Quality Risk Management, ICH Q9*
Lead agency counsel for final rules pertaining to human subject protection and clinical trial reporting*
*Matter handled prior to joining Hogan Lovells.
News
31 May 2022
Hogan Lovells Podcasts
25 March 2022
News
08 March 2022
News
23 February 2022
News
12 February 2022
News
12 February 2022